Joshua J. Travis

Joshua J. Travis is a strategic nonprofit leader dedicated to advancing equity and expanding access to opportunity. Over the course of his career, he has strengthened mission-driven organizations by building sustainable teams, securing new resources, and scaling programs that transform lives.

Travis has led the growth of nationally recognized initiatives such as Becoming a Man (BAM) and Working on Womanhood (WOW) at Youth Guidance, expanding evidence-based mentoring programs that equip young people with the skills to succeed in school and beyond. He has also supported local nonprofits in developing the infrastructure to become trusted hubs for education, advocacy, and resource-sharing in their communities.

In the health sector, Travis has worked with the Global Alzheimer’s Platform Foundation and the Alzheimer’s Association, advancing efforts to improve clinical trial access and ensure that underrepresented communities are included in the future of treatment and care. His approach blends community engagement, fundraising, policy strategy, and data-driven impact—always centering equity and long-term sustainability.

Travis holds a Bachelor’s degree in Anthropology with minors in Biological Sciences and Criminal Justice from Illinois State University, a Master’s in Nonprofit Management from DePaul University, and is currently pursuing a Doctorate in Interdisciplinary Leadership at Governors State University. Known for his ability to translate vision into action, he continues to help organizations navigate complexity while staying true to their mission.

Captain Julius Pryor III

Captain Julius Pryor is a recognized leader in leveraging diversity, equity, and inclusion (DEI) to accelerate innovation and deliver business results. Over the course of his career, he has created and led groundbreaking strategies at six global corporations, often serving as the first executive in newly established diversity leadership roles. He has held senior positions at Johnson & Johnson, Coca-Cola Enterprises, Abbott, Russell Athletic, Takeda, Cerner, and Genentech (Roche), where he served as Head of Innovation, Diversity & Inclusion.

Pryor approaches DEI not as a compliance function but as a driver of revenue, market share, and breakthrough thinking. By building organizational “diversity maturity,” he helps companies generate ideas across traditional boundaries and empower leaders to make smarter, more inclusive decisions.

His leadership philosophy was shaped in the U.S. Navy, where he rose to the rank of Captain and served as a Surface Warfare Officer, instructor, and commanding officer. He held posts in both the Atlantic and Pacific fleets and was a member of the historic re-commissioning crew of the USS Missouri (BB-63). He credits the Navy with instilling in him an uncompromising commitment to results and responsibility.

Pryor is Chair of the Board of Directors at the Center for Healthcare Innovation and also serves on the boards of the Andrew Young Center for Global Leadership and AArete Corporation. A graduate of Morehouse College and The Williston Northampton School, he is the author of Thriving in a Disruptive World: 6 Critical Concepts for Navigating the 21st Century. He was initiated into the Psi Chapter of the Omega Psi Phi Fraternity at Morehouse.

John Oyler

John V. Oyler co-founded BeOne in 2010 and has served as Chief Executive Officer and Chairman of the Board since its inception.

Mr. Oyler previously served as President and CEO of BioDuro, LLC until its acquisition by PPD, and as CEO of Galenea Corp., a biopharmaceutical company focused on therapies for central nervous system diseases. Before that, he was President of Telephia, Inc., an information company he founded and later sold to The Nielsen Company. He also served as co-CEO of Genta Incorporated (NASDAQ: GNTA), an oncology-focused biopharmaceutical company. He began his career as a management consultant at McKinsey & Company.

Mr. Oyler has served on the Board of Directors of the Biotechnology Innovation Organization (BIO) and currently serves on the Stanford Graduate School of Business Advisory Council. He holds a B.S. in mechanical engineering from MIT and an MBA from Stanford University. A Pittsburgh native, he is an avid Steelers and Penguins fan and enjoys skiing and spending time with his family.

Lynn Hanessian

Lynn Hanessian is founder of The Engager Company, a health and innovation-dedicated consultancy. Lynn is a trusted strategic communications leader and health industry advisor. For over 40 years, she has worked alongside biopharma, biotech and health technology companies; hospitals, health systems and payers; and medical societies and patient advocacy groups to foster trust, strengthen reputations, and drive business impact. Her expertise spans all stages of the innovation life cycle, corporate positioning, stakeholder engagement, and C-suite counsel. Lynn’s counsel is grounded in data, insights and forward-thinking solutions.

Lynn is a partner for global innovators, promising early-stage companies, leading healthcare systems and other organizations dedicated to advancing health. She guides organizations to anticipate and prepare for what is coming around the next corner—engaging with new audiences, mapping trust-building strategies, launching products, or elevating new perspectives. Her business acumen, creativity, and collaboration come together to unlock opportunities for impact and growth in an evolving healthcare landscape.

Prior to founding Engager, Lynn served as the chief health strategist for global communications leader, Edelman. She also held positions with the American Academy of Pediatrics, The Ounce of Prevention Fund and The University of Chicago Medical Center and School of Social Service Administration. Lynn has a BS in Economics from The University of Chicago.

Dr. Pierre Theodore

Pierre R. Theodore is an Unreasonable Mentor who participated in Unreasonable GOALS 2017 and has advised more than 16 Unreasonable companies. He currently serves as Executive Director of Health Equity at Genentech, where he leads a team dedicated to improving access to biotechnology innovations and ensuring that pharmacologic therapeutics are accessible to all patients.

Dr. Theodore is also a Clinical Associate Professor of Surgery at Stanford University School of Medicine, where he remains active in surgical care, education, and innovation. With over two decades of experience in thoracic surgery, global health, and medical innovation, he previously held leadership roles at Johnson & Johnson—including Vice President of Global External Innovation and Vice President of Medical Devices—advancing oncology research, medical technologies, and global surgical initiatives.

A longtime advocate for global health equity, Pierre serves on the Board of Directors of the St. Boniface Haiti Foundation and previously served on the Board of Catholic Charities San Francisco. He is a former Commander in the U.S. Navy Reserve Medical Corps, completing 16 years of service.

Pierre’s earlier career includes faculty leadership at UCSF in thoracic oncology, the founding of Parnassus Medical Technology, and clinical work in Paris at La Pitié-Salpêtrière Hospital. His training spans Johns Hopkins Hospital, Harvard Medical School’s Transplant Biology Research Center, the University of Virginia School of Medicine, and a Bachelor’s degree in Philosophy from Princeton University. He also holds an MPH in Health Equity from the Yale School of Public Health.

Anand Reddi

Anand Reddi is the Vice President of Global Strategic Initiatives and Corporate Operations at BeOne Medicines, where he also serves as Chief of Staff to the Chief Executive Officer. He plays a central role in shaping enterprise strategy, advancing corporate operations, and supporting the CEO in executing BeOne’s global mission.

Before joining BeOne, Mr. Reddi held senior leadership positions spanning biotechnology, global health, and corporate strategy. At Adverum Biotechnologies, he served on the Executive Committee as Vice President of Corporate Strategy, Corporate Affairs, and Investor Relations, helping guide programs in ocular gene therapy. Previously, he spent seven years at Gilead Sciences in roles across medical affairs, emerging markets, corporate affairs, product strategy, global marketing, and digital innovation. During this period, he contributed to major therapeutic launches and helped expand access to lifesaving medicines in low-resource settings across more than 130 countries.

Mr. Reddi’s career began in scientific research, clinical studies, and health policy, with a longstanding focus on HIV, global health financing, and health-systems strengthening. His commentary on global medicine access and public health has appeared in leading national publications, and he has served on multiple nonprofit and corporate boards dedicated to health equity and innovation.

He holds dual degrees in history and biology from the University of Michigan and pursued medical and public health training as an M.D./M.Sc. candidate at the University of Colorado School of Medicine. As a J. William Fulbright Scholar in South Africa, he conducted research on HIV and healthcare system development.

Amy Shohet

Amy Shohet is a licensed clinical social worker with 30 years of experience supporting children, families, couples, and individuals through life transitions, trauma, and healing. She specializes in early childhood mental health and believes deeply that connection is the foundation for meaningful and lasting change.

As One Life Counseling’s Director of Early Childhood Mental Health Services at One Life Counseling Services, Amy oversees programs designed to support the emotional well-being of young children and their caregivers. She is a Certified Synergetic Play Therapist, a Zero to Three Certified Trainer in The Growing Brain, and is currently partnering with UCSF to train a cohort of 15 therapists in Child-Parent Psychotherapy (CPP). Her clinical specialties include CPP, Synergetic Play Therapy, Brainspotting, the Neurosequential Model of Therapeutics (NMT), Family Therapy, Couples Counseling and Relationship Therapy.

Amy works closely with children and families to navigate trauma, overcome anxiety, strengthen relationships, and build emotional resilience. She incorporates play-based modalities, neurobiologically informed frameworks, and caregiver–child relational work to help young children feel safe, understood, and connected. Her passion for early childhood guides her approach in supporting both children and the adults who care for them.

Originally from the East Coast, Amy holds a Master’s in Social Work from Columbia University and a Bachelor’s degree in Psychology and Education from Mount Holyoke College. Her professional background spans hospitals, schools (where she served as a certified teacher), legal settings, community agencies, and higher education—having worked in admissions at the Stanford University Graduate School of Business.

In addition to her clinical work, Amy is an experienced supervisor who enjoys mentoring new therapists and supporting their professional growth.

Outside of her professional life, Amy is an accomplished marathon runner, an active community volunteer, and enjoys spending time with her family and her dog, Jeter.

Rochelle Williams - Belizaire

Rochelle Williams‑Belizaire believes that advancing health equity in clinical research begins with giving patients and communities agency, knowledge, and access. She champions a patient‑first approach: patients lead, and the research ecosystem follows. In full collaboration with communities, clinicians, and patient advocates, Rochelle designs innovative enrollment models and systems that equip communities with the data, resources, and tools needed to understand clinical trial opportunities and make informed decisions about participation.

With over a decade of experience across academia, small biotech, and global pharmaceutical companies, she has built enterprise clinical trial diversity strategies, implemented scalable equity-driven solutions, and led global initiatives that embed patient-first principles into trial design and site engagement. She leverages strategic partnerships, translational science, and clinical research administration to ensure that innovation reaches the patients who can benefit most.

A certified public health expert and passionate pediatric hematology caregiver, Rochelle draws on her firsthand experience as an immigrant, female, minority, and caregiver to drive meaningful change in healthcare. Her personal insights fuel her professional mission—integrating community-based participatory research, patient advocacy, and actionable data to remove barriers and expand access—ensuring clinical trials are inclusive, equitable, and truly centered around the patients and communities they are designed to serve.

Rochelle currently leads clinical trial diversity at BeOne Medicines.

Melika Davis

Melika Davis is the Senior Vice President and Global Head of Clinical Operations at BeOne, a role she has held since 2019. She leads the company’s global clinical operations strategy and oversees the execution of development programs across BeOne’s portfolio. Throughout her career, Ms. Davis has been committed to advancing the science and efficiency of clinical trials and has contributed to the successful introduction of 20 therapeutic products to the market.

Before joining BeOne, Ms. Davis spent more than a decade at Novartis, where she guided large-scale clinical monitoring and development quality initiatives, ultimately serving as Senior Vice President and Global Head of Drug Development Quality. Her earlier career includes 13 years at Schering-Plough, where she held multiple leadership positions within research and development and helped support the growth of key therapeutic programs.

Ms. Davis holds a B.S. in biology and an M.S. in molecular biology from Texas Woman’s University, along with a licence de physiologie from the University of Sciences in Nice, France.